Adcetris (brentuximab vedotin)

pCPA File Number: 21034
Negotiation Status:
Concluded with an LOI
Indication(s):
Hodgkin's Lymphoma
Sponsor/Manufacturer:
Seattle Genetics Inc.
CDA-AMC Project Number:
PC0116-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: